Item 8.01 Other Events.

On June 7, 2021, Greenwich LifeSciences, Inc. issued a press release presenting an abstract and poster of the final 5 year GP2 Phase IIb clinical trial safety data at the 2021 ASCO Annual Meeting. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

Item 9.01 Financial Statements and Exhibits.





(d) Exhibits.




Exhibit No.               Description

99.1            Press release dated June 7, 2021




-2-

© Edgar Online, source Glimpses